Related references
Note: Only part of the references are listed.The prefrontal cortex: a target for antipsychotic drugs
F. Artigas
ACTA PSYCHIATRICA SCANDINAVICA (2010)
Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats
Yuji Kitaichi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered
Ian Hindmarch et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment
Georgios Paslakis et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Neurotransmitters and prefrontal cortex-limbic system interactions: implications for plasticity and psychiatric disorders
Alberto Del Arco et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients
Cornelius Schuele et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine
Brijesh G. Taksande et al.
NEUROPHARMACOLOGY (2009)
Neuroactive steroid regulation of neurotransmitter release in the CNS: Action, mechanism and possible significance
Ping Zheng
PROGRESS IN NEUROBIOLOGY (2009)
Role of Prefrontal Dopaminergic Neurotransmission in Glucocorticoid Receptor-Mediated Modulation of Methamphetamine-Induced Hyperactivity
Yukio Ago et al.
SYNAPSE (2009)
Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands
E. J. Cobos et al.
CURRENT NEUROPHARMACOLOGY (2008)
Measurement of immediate-early gene activation-c-fos and beyond
K. J. Kovacs
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP3 Receptors and Cellular Signaling Pathways
Tomoko Nishimura et al.
PLOS ONE (2008)
High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine:: A positron emission tomography study using [11C]SA4503
Masatomo Ishikawa et al.
BIOLOGICAL PSYCHIATRY (2007)
Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice
Yukio Ago et al.
SYNAPSE (2007)
Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior:: Comparison with paroxetine
Nobuaki Egashira et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: Role of sigma-1 receptors
Kenji Hashimoto et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Propofol acts at the sigma-1 receptor and inhibits pentazocine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices
M. Yamada et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2006)
Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder
Maria Carolina Hardoy et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex
M Huang et al.
PSYCHOPHARMACOLOGY (2006)
Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor
T Izumi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
The role of sigma receptors in depression
JE Bermack et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex
Y Ago et al.
NEUROPSYCHOPHARMACOLOGY (2005)
sigma-1 receptor ligands - Potential in the treatment of neuropsychiatric disorders
T Hayashi et al.
CNS DRUGS (2004)
Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex
Y Ago et al.
NEUROPHARMACOLOGY (2003)
Preserved sigma1 (σ1) receptor expression and behavioral efficacy in the aged C57BL/6 mouse
VL Phan et al.
NEUROBIOLOGY OF AGING (2003)
Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration
E Castro et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Strain differences in σ1 receptor-mediated behaviours are related to neurosteroid levels
VL Phan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex
FP Bymaster et al.
PSYCHOPHARMACOLOGY (2002)
Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?
CE Renard et al.
PSYCHOPHARMACOLOGY (2001)
The interaction between neuroactive steroids and the σ1 receptor function:: behavioral consequences and therapeutic opportunities
T Maurice et al.
BRAIN RESEARCH REVIEWS (2001)
Altered salivary dehydroepiandrosterone levels in major depression in adults
A Michael et al.
BIOLOGICAL PSYCHIATRY (2000)
Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex
W Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Share Paper
